Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Repeat PSA Test Recommended Before Prostate Biopsy

By HospiMedica staff writers
Posted on 12 Jun 2003
A study has found that levels of prostate-specific antigen (PSA) fluctuate in men, so that a moderately elevated level does not necessarily warrant a prostate biopsy. More...
The finding was reported in the May 28, 2003, issue of the Journal of the American Medical Association (JAMA).

The PSA blood test is part of routine screening for most men over 50, and when moderately elevated levels of PSA are found, a biopsy is currently recommended. In the retrospective study, involving 972 men with a median age of 62, researchers found that while 21% had an elevated PSA (> 4.0 ng/ml) at some point over a four-year period, the level later returned to normal in nearly 50% of the men and remained normal in further tests. As a result, the researchers suggest that a biopsy not be performed until the PSA test is repeated.

"A single, elevated PSA level does not automatically warrant a prostate biopsy,” said lead author Dr. James Eastham, a surgeon in the department of urology at Memorial Sloan-Kettering Cancer Center (New York, NY, USA). "We recommend having the findings confirmed by repeating the PSA test after waiting at least six weeks. Even if the repeat test shows an elevated level, prostate cancer will only be discovered in about one quarter of men who undergo biopsy.”


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Monitor/Defibrillator
Zenix
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.